Garden State Dispatch
SEE OTHER BRANDS

Following the news from New Jersey

Garden State Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Garden State Dispatch.

Press releases published on May 1, 2025

Dr. Juan P. Chisholm, Author of Mission Possible is recognized as a Distinguished Favorite Winner for Overall Excellence

Dr. Juan P. Chisholm, Author of Mission Possible is recognized as a Distinguished Favorite Winner for Overall Excellence

Dr. Juan P. Chisholm, Author of Mission Possible is recognized as a 2025 Distinguished Favorite Winner from the Independent Press Award for Overall Excellence. NEWARK, NJ, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Dr. Juan P. Chisholm, Author of …

Commercial Solar Panel Recycling  Honored by CIANJ for State-of-the-Art Environmental Innovation on Earth Day

Commercial Solar Panel Recycling Honored by CIANJ for State-of-the-Art Environmental Innovation on Earth Day

CSPR honored by CIANJ for leading solar panel recycling innovation, spotlighting scalable, zero-landfill solutions this Earth Day in New Jersey. PHILLIPSBURG, NJ, UNITED STATES, May 1, 2025 /⁨EINPresswire.com⁩/ -- Commercial Solar Panel Recycling (CSPR) …

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

Channel Therapeutics Provides Announcement on 2024 Annual Report to Comply with NYSE American Listing Rules

FREEHOLD, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously disclosed in …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

Middlesex Water Company Reports First Quarter 2025 Earnings

Middlesex Water Company Reports First Quarter 2025 Earnings

Diluted earnings per share (“EPS”) of $0.53 Completed the acquisition of Ocean View water utility assets in Delaware Declared $0.34 common stock cash dividend Invested $19 million in water and wastewater utility infrastructure ISELIN, N.J., May 01, 2025 ( …

Acrow Bridge Provides Temporary Access for Pedestrians and Diverted Utilities in Stratford, London

Acrow Bridge Provides Temporary Access for Pedestrians and Diverted Utilities in Stratford, London

LYDNEY, GLOUCESTERSHIRE, U.K., May 01, 2025 (GLOBE NEWSWIRE) -- Acrow Bridge, a leading international bridge engineering and supply company, is pleased to note one of its modular steel bridges has been installed to carry pedestrians and diverted utilities …

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit

Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit

PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs targeting the tumor microenvironment (TME), today announced it …

Ocean Power Technologies Ships AI-Capable Merrows™ PowerBuoy®

Ocean Power Technologies Ships AI-Capable Merrows™ PowerBuoy®

MONROE TOWNSHIP, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has …

electroCore’s Truvaga™ Now Works with the Apple Health app

electroCore’s Truvaga™ Now Works with the Apple Health app

ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that its flagship wellness product, Truvaga Plus, now works with the Apple® Health app. …

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025

BASKING RIDGE, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious …

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

VOQUEZNA launch momentum continues with over 390,000 prescriptions filled to date, written by more than 23,600 healthcare providers Net revenues of $28.5 million reported for Q1 Filled VOQUEZNA prescriptions increased ~8% in Q1 over the prior quarter …

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

Climb Channel Solutions Launches Global Partnership with Accelsius LLC

EATONTOWN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), is excited to announce its new partnership with …

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET

Aquestive Therapeutics to Report First Quarter 2025 Financial Results and Recent Business Highlights on May 12 and Host Conference Call on May 13 at 8:00 a.m. ET

WARREN, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

Amicus Therapeutics Announces First Quarter 2025 Financial Results and Corporate Updates

1Q 2025 Total Revenue of $125.2M, a 15% Increase Year-over-Year at CER Expanding Portfolio through In-Licensing of DMX-200 Phase 3 Program for Rare Kidney Disease with Significant Market Potential in the U.S. Maintaining 2025 Guidance for Galafold, …

Radware Lands Largest Cloud Security Services Agreement to Date

Radware Lands Largest Cloud Security Services Agreement to Date

MAHWAH, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced it recorded a major customer win, securing its largest cloud security …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service